Journal
PROTEIN SCIENCE
Volume 31, Issue 12, Pages -Publisher
WILEY
DOI: 10.1002/pro.4479
Keywords
AlphaFold; cancer mutations; protein-protein interactions; structure prediction; cancer interactome
Categories
Funding
- Cancer Prevention and Research Institute of Texas [RP210041]
- Welch Foundation [I-2095-20220331]
- Endowed Scholars Program of UTSouthwestern
Ask authors/readers for more resources
Protein-protein interactions (PPIs) are crucial in cellular processes and their perturbation is important in cancer. Using deep learning methods like AlphaFold, we predicted cancer-related PPIs and gained structural insights into cancer-related processes. Additionally, we explored the cancer mutation landscape on PPI interfaces, revealing functional preferences and potential drug targets.
Protein-protein interactions (PPIs) are involved in almost all essential cellular processes. Perturbation of PPI networks plays critical roles in tumorigenesis, cancer progression, and metastasis. While numerous high-throughput experiments have produced a vast amount of data for PPIs, these data sets suffer from high false positive rates and exhibit a high degree of discrepancy. Coevolution of amino acid positions between protein pairs has proven to be useful in identifying interacting proteins and providing structural details of the interaction interfaces with the help of deep learning methods like AlphaFold (AF). In this study, we applied AF to investigate the cancer protein-protein interactome. We predicted 1,798 PPIs for cancer driver proteins involved in diverse cellular processes such as transcription regulation, signal transduction, DNA repair, and cell cycle. We modeled the spatial structures for the predicted binary protein complexes, 1,087 of which lacked previous 3D structure information. Our predictions offer novel structural insight into many cancer-related processes such as the MAP kinase cascade and Fanconi anemia pathway. We further investigated the cancer mutation landscape by mapping somatic missense mutations (SMMs) in cancer to the predicted PPI interfaces and performing enrichment and depletion analyses. Interfaces enriched or depleted with SMMs exhibit different preferences for functional categories. Interfaces enriched in mutations tend to function in pathways that are deregulated in cancers and they may help explain the molecular mechanisms of cancers in patients; interfaces lacking mutations appear to be essential for the survival of cancer cells and thus may be future targets for PPI modulating drugs.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available